These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15489659)

  • 1. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.
    Ribalta T; McCutcheon IE; Aldape KD; Bruner JM; Fuller GN
    Am J Surg Pathol; 2004 Nov; 28(11):1532-6. PubMed ID: 15489659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
    Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
    Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.
    Puripat N; Loharamtaweethong K
    Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.
    Duregon E; Cassenti A; Pittaro A; Ventura L; Senetta R; Rudà R; Cassoni P
    Neuro Oncol; 2015 May; 17(5):663-9. PubMed ID: 25646026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated Histone H3 (PHH3) as a Novel Cell Proliferation Marker and Prognosticator for Meningeal Tumors: A Short Review.
    Elmaci İ; Altinoz MA; Sari R; Bolukbasi FH
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):627-631. PubMed ID: 28777144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas.
    Kim YJ; Ketter R; Steudel WI; Feiden W
    Am J Clin Pathol; 2007 Jul; 128(1):118-25. PubMed ID: 17580279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningiomas: Objective assessment of proliferative indices by immunohistochemistry and automated counting method.
    Chavali P; Uppin MS; Uppin SG; Challa S
    Neurol India; 2017; 65(6):1345-1349. PubMed ID: 29133712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma.
    Bedekovics J; Irsai G; Hegyi K; Beke L; Krenács L; Gergely L; Méhes G
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):579-585. PubMed ID: 27997502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphohistone-H3 Proliferation Index Is Superior to Mitotic Index and MIB-1 Expression as a Predictor of Recurrence in Human Meningiomas.
    Winther TL; Arnli MB; Salvesen Ø; Torp SH
    Am J Clin Pathol; 2016 Oct; 146(4):510-20. PubMed ID: 27686177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
    Saffar H; Okhovat H; Arbabsoleymani S; Tavangar SM; Khoshnevisan A; Hajinasrollah G; Hamidi Afra Z; Saffar H
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2049-2052. PubMed ID: 34319026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
    Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
    Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphohistone H3 expression correlates with manual mitotic counts and aids in identification of "hot spots" in fibroepithelial tumors of the breast.
    Ginter PS; Shin SJ; Liu Y; Chen Z; D'Alfonso TM
    Hum Pathol; 2016 Mar; 49():90-8. PubMed ID: 26826415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.
    Ibrahim A; Toss MS; Makhlouf S; Miligy IM; Minhas F; Rakha EA
    Histopathology; 2023 Feb; 82(3):393-406. PubMed ID: 36349500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma.
    Casper DJ; Ross KI; Messina JL; Sondak VK; Bodden CN; McCardle TW; Glass LF
    Am J Dermatopathol; 2010 Oct; 32(7):650-4. PubMed ID: 20559123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks?
    Solomides CC; Birbe RC; Nicolaou N; Bagley D; Bibbo M
    Acta Cytol; 2012; 56(3):285-8. PubMed ID: 22555531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas.
    Schimming TT; Grabellus F; Roner M; Pechlivanis S; Sucker A; Bielefeld N; Moll I; Schadendorf D; Hillen U
    Am J Dermatopathol; 2012 May; 34(3):266-9. PubMed ID: 22197861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors.
    Kim MJ; Kwon MJ; Kang HS; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Park HC
    Biomed Res Int; 2018; 2018():1013640. PubMed ID: 29780816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving precise counting of mitotic cells in mantle cell lymphoma using phosphohistone H3 (PHH3) antibody.
    Medani H; Elshiekh M; Naresh KN
    J Clin Pathol; 2021 Oct; 74(10):646-649. PubMed ID: 32873701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.